| Kristina Torrence, MD | |
|
1165 Imperial Dr Ste 300, Hagerstown, MD 21740-6556 | |
| (301) 665-9098 | |
| (301) 665-9096 |
| Full Name | Kristina Torrence |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 15 Years |
| Location | 1165 Imperial Dr Ste 300, Hagerstown, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598025009 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | D0083000 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Womens Care Llc | 4880582741 | 248 |
News Archive
Today a United States District Court judge certified a nationwide, class-action lawsuit against McKesson Corporation on behalf of municipalities claiming McKesson engaged in a scheme to inflate fraudulently the price of more than 400 brand-name prescription drugs, including blockbusters such as Prozac, Lipitor, Zocor and Vioxx.
NephroGenex, Inc., a privately held drug development company focusing on kidney disease, today announced the completion of patient enrollment in its Phase 2b clinical trial (PYR-210) studying the safety and efficacy of its lead drug candidate Pyridorin (pyridoxamine dihydrochloride) in type 2 diabetic patients with overt diabetic nephropathy. Three hundred and seventeen (317) patients have been randomized.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced U.S. Food and Drug Administration (FDA) conditional approval for an Investigational Device Exemption (IDE) application to initiate the pivotal trial to evaluate the Tryton Side Branch Stent System for the treatment of coronary artery disease.
A new research study has shown that volunteering regularly over time may have benefits for older adults. The study was published in the Journal of the American Geriatrics Society.
› Verified 5 days ago
| Entity Name | Capital Womens Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679534069 PECOS PAC ID: 4880582741 Enrollment ID: O20050804000705 |
News Archive
Today a United States District Court judge certified a nationwide, class-action lawsuit against McKesson Corporation on behalf of municipalities claiming McKesson engaged in a scheme to inflate fraudulently the price of more than 400 brand-name prescription drugs, including blockbusters such as Prozac, Lipitor, Zocor and Vioxx.
NephroGenex, Inc., a privately held drug development company focusing on kidney disease, today announced the completion of patient enrollment in its Phase 2b clinical trial (PYR-210) studying the safety and efficacy of its lead drug candidate Pyridorin (pyridoxamine dihydrochloride) in type 2 diabetic patients with overt diabetic nephropathy. Three hundred and seventeen (317) patients have been randomized.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced U.S. Food and Drug Administration (FDA) conditional approval for an Investigational Device Exemption (IDE) application to initiate the pivotal trial to evaluate the Tryton Side Branch Stent System for the treatment of coronary artery disease.
A new research study has shown that volunteering regularly over time may have benefits for older adults. The study was published in the Journal of the American Geriatrics Society.
› Verified 5 days ago
| Entity Name | Obhg Maryland Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851657894 PECOS PAC ID: 3577728211 Enrollment ID: O20120703000447 |
News Archive
Today a United States District Court judge certified a nationwide, class-action lawsuit against McKesson Corporation on behalf of municipalities claiming McKesson engaged in a scheme to inflate fraudulently the price of more than 400 brand-name prescription drugs, including blockbusters such as Prozac, Lipitor, Zocor and Vioxx.
NephroGenex, Inc., a privately held drug development company focusing on kidney disease, today announced the completion of patient enrollment in its Phase 2b clinical trial (PYR-210) studying the safety and efficacy of its lead drug candidate Pyridorin (pyridoxamine dihydrochloride) in type 2 diabetic patients with overt diabetic nephropathy. Three hundred and seventeen (317) patients have been randomized.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced U.S. Food and Drug Administration (FDA) conditional approval for an Investigational Device Exemption (IDE) application to initiate the pivotal trial to evaluate the Tryton Side Branch Stent System for the treatment of coronary artery disease.
A new research study has shown that volunteering regularly over time may have benefits for older adults. The study was published in the Journal of the American Geriatrics Society.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristina Torrence, MD 8110 Maple Lawn Blvd Ste 235, Fulton, MD 20759-2693 Ph: (301) 340-8339 | Kristina Torrence, MD 1165 Imperial Dr Ste 300, Hagerstown, MD 21740-6556 Ph: (301) 665-9098 |
News Archive
Today a United States District Court judge certified a nationwide, class-action lawsuit against McKesson Corporation on behalf of municipalities claiming McKesson engaged in a scheme to inflate fraudulently the price of more than 400 brand-name prescription drugs, including blockbusters such as Prozac, Lipitor, Zocor and Vioxx.
NephroGenex, Inc., a privately held drug development company focusing on kidney disease, today announced the completion of patient enrollment in its Phase 2b clinical trial (PYR-210) studying the safety and efficacy of its lead drug candidate Pyridorin (pyridoxamine dihydrochloride) in type 2 diabetic patients with overt diabetic nephropathy. Three hundred and seventeen (317) patients have been randomized.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced U.S. Food and Drug Administration (FDA) conditional approval for an Investigational Device Exemption (IDE) application to initiate the pivotal trial to evaluate the Tryton Side Branch Stent System for the treatment of coronary artery disease.
A new research study has shown that volunteering regularly over time may have benefits for older adults. The study was published in the Journal of the American Geriatrics Society.
› Verified 5 days ago
Dr. David Henry Solberg, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1165 Imperial Dr, Ste 300, Hagerstown, MD 21740 Phone: 301-665-9098 Fax: 301-665-9096 | |
Gary Wayne Smith, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 11110 Medical Campus Rd, Suite 249, Hagerstown, MD 21742 Phone: 301-714-4100 Fax: 301-714-4101 | |
Jay B Greenberg, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1130 Professional Ct, Hagerstown, MD 21740 Phone: 301-791-5555 Fax: 301-791-8104 | |
Jennifer Elaine Kuhn, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 11110 Medical Campus Rd, Suite 249, Hagerstown, MD 21742 Phone: 301-714-4100 Fax: 301-714-4101 | |
Dr. Jowheri J Mullick, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1130 Professional Ct, Hagerstown, MD 21740 Phone: 301-791-5555 Fax: 301-791-8104 | |
Dr. Andrew Joseph Oh, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1165 Imperial Dr, Ste 300, Hagerstown, MD 21740 Phone: 301-665-9098 Fax: 301-665-9096 | |
Dr. Lisa N Miller, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1165 Imperial Drive, Suite 300, Hagerstown, MD 21740 Phone: 301-665-9098 Fax: 301-665-9096 |